AI assistant
SURMODICS INC — Director's Dealing 2019
Jul 3, 2019
32845_dirs_2019-07-03_0e9241ca-c6fd-4f9c-b968-16b05999a671.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: SURMODICS INC (SRDX)
CIK: 0000924717
Period of Report: 2019-07-01
Reporting Person: Maharaj Gary R (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2019-07-01 | Common Stock | S | 1970 | $42.176 | Disposed | 150235 | Direct |
| 2019-07-01 | Common Stock | S | 3030 | $42.9738 | Disposed | 147205 | Direct |
Footnotes
F1: Sales effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 28, 2019.
F2: Reflects the weighted average price of 1,970 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on July 1, 2019 with sale prices ranging from $41.715 to $42.705 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F3: Reflects the weighted average price of 3,030 shares of common stock of Surmodics,Inc. sold by the reporting person in multiple transactions on July 1, 2019 with sale prices ranging from $42.71 to $43.34 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.